Desq Long
Sign in

Cluster

PHIO-2026-08-18-6d9a0e3283be

SEC FORM 4CLUSTER · 2 INSIDERS
$27,700.00

Phio Pharmaceuticals Corp. (PHIO)

Purchase of 25,000 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Bitterman Robert J, Chairman, Pres. & CEOPurchase of 10,000 shares at $1.06 per share.$10,600.00
  • Plott Ronald ToddPurchase of 15,000 shares at $1.14 per share.$17,100.00

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001683168-26-006592 · filed 2026-08-19 · View filing →

Source: SEC Form 4 · 0001683168-26-006620 · filed 2026-08-20 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Phio Pharmaceuticals Corp. (PHIO)." Disclosed 2026-08-20. https://desqlong.com/cards/cluster-PHIO-2026-08-18-6d9a0e3283be (retrieved 2026-09-26).